These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4991920)

  • 1. Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.
    Lorian V; Sabath LD
    Appl Microbiol; 1970 Nov; 20(5):754-6. PubMed ID: 4991920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.
    Sabath LD; Lorian V; Gerstein D; Loder PB; Finland M
    Appl Microbiol; 1968 Sep; 16(9):1288-92. PubMed ID: 4970991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin: in-vitro activity against clinical isolates.
    Grima P
    Chemioterapia; 1985 Dec; 4(6):434-5. PubMed ID: 3938347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
    Bremner DA
    Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxicillin, a new penicillin antibiotic.
    Handsfield HH; Clark H; Wallace JF; Holmes KK; Turck M
    Antimicrob Agents Chemother; 1973 Feb; 3(2):262-5. PubMed ID: 4208282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.
    Sabath LD; Gerstein DA; Loder PB; Finland M
    J Lab Clin Med; 1968 Dec; 72(6):916-23. PubMed ID: 4972710
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.
    Neu HC; Winshell EB
    Appl Microbiol; 1971 Jan; 21(1):66-70. PubMed ID: 4993233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Gram-negative bacilli to ampicillin after six years' clinical use.
    Slocombe B; Sutherland R
    J Clin Pathol; 1969 Nov; 22(6):644-8. PubMed ID: 4983462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial activity of ceftolozane/tazobactam against Enterobacteriaceae and Pseudomonas aeruginosa in the Czech Republic in 2016].
    Žemličková H; Jakubů V; Fridrichová M
    Klin Mikrobiol Infekc Lek; 2017 Dec; 23(4):132-135. PubMed ID: 29378381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.
    Leng B; Meyers BR; Hirschman SZ; Keusch GT
    Antimicrob Agents Chemother; 1975 Aug; 8(2):164-71. PubMed ID: 810077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
    Hirsch EB; Raux BR; Zucchi PC; Kim Y; McCoy C; Kirby JE; Wright SB; Eliopoulos GM
    Int J Antimicrob Agents; 2015 Dec; 46(6):642-7. PubMed ID: 26498988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of rosamicin and erythromycin against urinary tract pathogens.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1979 Jul; 16(1):69-73. PubMed ID: 112920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of netilmicin compared with other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriological and clinical evaluation of the combination of cloxacillin with ampicillin.
    Klastersky J; Debusscher L; Rühl D
    Chemotherapy; 1972; 17(6):382-91. PubMed ID: 4628324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.